Drug profile · INN
desvenlafaxine succinate
DESVENLAFAXINE SUCCINATE
desvenlafaxine succinate (DESVENLAFAXINE SUCCINATE) is a serotonin transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — desvenlafaxine succinate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
desvenlafaxine succinate (DESVENLAFAXINE SUCCINATE) is a serotonin transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is desvenlafaxine succinate?
desvenlafaxine succinate (DESVENLAFAXINE SUCCINATE) is a serotonin transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for desvenlafaxine succinate?
DESVENLAFAXINE SUCCINATE is a marketed brand name for desvenlafaxine succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desvenlafaxine succinate?
desvenlafaxine succinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.